Thursday, 02 April 2020

Australia News

  • Russell Howard to join Prima BioMed board

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 09 May, 2013

    Singapore: Prima BioMed has appointed Dr Russell J Howard as a non-executive director with immediate effect. Dr Howard brings a strong scientific background and significant executive-level ...Read more

  • Prana provides update on Huntington Disease trial

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Melbourne-based Prana Biotechnology released an update on the Huntington Disease trial. The company reported the progress in the Reach2HD trial at the Huntington Study Group Annu...Read more

  • Starpharma to receive $6 mn for overseas R&D

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for overseas research activities related to VivaGel. Starpharma has made...Read more

  • Bluechiiip signs deal with Inpeco

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 22 Oct, 2012

    Singapore: Bluechiip has signed a term sheet to execute a collaborative co-development agreement with swiss company Inpeco SA which allows both parties to collaborate to develop Inpeco pro...Read more

  • CardioCel tissue patch enhances stem cell survival

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Feb, 2013

    Singapore: Australia's Allied Healthcare's CardioCel tissue patches has shown superiority for stem cells survival and growth as compared to the gold-standard tissues in surgical use. Joint...Read more

  • Hatchtech publishes safety data for DeOvo

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2012

    Singapore: Australia-based specialty pharmaceutical company Hatchtech published data describing the mechanism of action of the active ingredient (Ha44) in its lead head lice product DeOvo, ...Read more

  • Phylogica to convert notes to raise $1.6 mn

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

    Singapore: Phylogica has agreed to raise $1.6 million of new capital through a placement of 16,000 unlisted converting notes each with an issue price of $100. The issue of the converting no...Read more

  • Aus univ gets massive funding for TB, HPV R&D

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jan, 2013

    Singapore: University of Queensland (UQ) has secured support from the federal government for two research of its projects, aimed at treating papilloma virus and tuberculosis infections. The...Read more

  • Quest signs $2mn development deal with Korean firm

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    Singapore: Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cancer, entered into a long term strategic relationship with AD Biotech, a...Read more

  • BREVAGen's launch features on Australian TV

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

    Singapore: Genetic Technologies revealed that a story highlighting the BREVAGen test and its successful US launch featured nationally across Australian TV. The story was broadcast on last n...Read more

  • APAC healthcare industry becomes cloud friendly

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is embracing the full gamut of cloud provided services from infrastructure...Read more

  • Starpharma's VP becomes CEO of Viralytics

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Starpharma's vice president, Dr Malcolm McColl, has been appointed CEO, Viralytics. Prior to this, Dr McColl was VP, business development, Starpharma, since 2010. He has worked...Read more

  • Bluechiip, Gentris sign cryogenic sample management deal

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

    Singapore: Bluechiip, which has developed a unique temperature sensing and tracking solution initially for cryogenic sample management in the healthcare and life science industry, signed a...Read more

  • Heartware receives FDA approval for HeartWare Ventricular Assist System

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

    Singapore: HeartWare International, a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, an...Read more

  • Bionomics begins phase I trial of anxiety drug

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

    Singapore: Bionomics has been advised by its licensee, Ironwood Pharmaceuticals, that following the submission of an Investigational New Drug (IND) application to the US FDA last month, th...Read more

  • TGA admits error in clinical trial tracking

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Australia's Therapeutic Goods Administration (TGA) has identified errors in its internal reports regarding the numbers of clinical trial conducted from July 1, 2009-to-December ...Read more

  • Telesso gets $6.5m to develop acne treatment

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Sep, 2013

    Singapore: Australia-based Telesso Technologies raised $6.5 million capital in connection with its acquisition of Mimetica and its re-listing on the Australian Securities Exchange (ASX). Th...Read more

  • Top 20 APAC Country Analysis: Korea

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2015

    Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Ministry of Food and Drug Safety (MFDS) stated that medicine exports of th...Read more